{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T22:52:28Z","timestamp":1788562348933,"version":"build-2803163510"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T00:00:00Z","timestamp":1704758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T00:00:00Z","timestamp":1704758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"DOI":"10.1007\/s10143-023-02273-0","type":"journal-article","created":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T03:01:42Z","timestamp":1704769302000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Risks of nimodipine dose reduction during the high-risk period for delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2925-8537","authenticated-orcid":false,"given":"Claudia","family":"Ditz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria V.","family":"Matone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bram","family":"Schwachenwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"K\u00fcchler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,9]]},"reference":[{"issue":"7","key":"2273_CR1","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1161\/STROKEAHA.115.009288","volume":"46","author":"J Huhtakangas","year":"2015","unstructured":"Huhtakangas J, Lehto H, Seppa K, Kivisaari R, Niemela M, Hernesniemi J, Lehecka M (2015) Long-term excess mortality after aneurysmal subarachnoid hemorrhage: patients with multiple aneurysms at risk. Stroke 46(7):1813\u20131818. https:\/\/doi.org\/10.1161\/STROKEAHA.115.009288","journal-title":"Stroke"},{"issue":"9558","key":"2273_CR2","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/S0140-6736(07)60153-6","volume":"369","author":"J van Gijn","year":"2007","unstructured":"van Gijn J, Kerr RS, Rinkel GJ (2007) Subarachnoid haemorrhage. Lancet 369(9558):306\u2013318. https:\/\/doi.org\/10.1016\/S0140-6736(07)60153-6","journal-title":"Lancet"},{"issue":"6","key":"2273_CR3","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1161\/STR.0b013e3182587839","volume":"43","author":"ES Connolly Jr","year":"2012","unstructured":"Connolly ES Jr, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT, Hoh BL, Kirkness CJ, Naidech AM, Ogilvy CS, Patel AB, Thompson BG, Vespa P, American Heart Association Stroke C, Council on Cardiovascular R, Intervention, Council on Cardiovascular N, Council on Cardiovascular S, Anesthesia, Council on Clinical C (2012) Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association\/american Stroke Association. Stroke 43(6):1711\u20131737. https:\/\/doi.org\/10.1161\/STR.0b013e3182587839","journal-title":"Stroke"},{"issue":"7","key":"2273_CR4","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1038\/jcbfm.2011.56","volume":"31","author":"MD Vergouwen","year":"2011","unstructured":"Vergouwen MD, Etminan N, Ilodigwe D, Macdonald RL (2011) Lower incidence of cerebral infarction correlates with improved functional outcome after aneurysmal subarachnoid hemorrhage. J Cereb Blood Flow Metab 31(7):1545\u20131553. https:\/\/doi.org\/10.1038\/jcbfm.2011.56","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"2273_CR5","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1161\/STROKEAHA.110.597005","volume":"42","author":"RW Crowley","year":"2011","unstructured":"Crowley RW, Medel R, Dumont AS, Ilodigwe D, Kassell NF, Mayer SA, Ruefenacht D, Schmiedek P, Weidauer S, Pasqualin A, Macdonald RL (2011) Angiographic vasospasm is strongly correlated with cerebral infarction after subarachnoid hemorrhage. Stroke 42(4):919\u2013923. https:\/\/doi.org\/10.1161\/STROKEAHA.110.597005","journal-title":"Stroke"},{"issue":"3","key":"2273_CR6","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1080\/02688699550041403","volume":"9","author":"NW Dorsch","year":"1995","unstructured":"Dorsch NW (1995) Cerebral arterial spasm\u2013a clinical review. Br J Neurosurg 9(3):403\u2013412. https:\/\/doi.org\/10.1080\/02688699550041403","journal-title":"Br J Neurosurg"},{"issue":"12","key":"2273_CR7","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1136\/jnnp-2014-307711","volume":"85","author":"KP Budohoski","year":"2014","unstructured":"Budohoski KP, Guilfoyle M, Helmy A, Huuskonen T, Czosnyka M, Kirollos R, Menon DK, Pickard JD, Kirkpatrick PJ (2014) The pathophysiology and treatment of delayed cerebral ischaemia following subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 85(12):1343\u20131353. https:\/\/doi.org\/10.1136\/jnnp-2014-307711","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"2273_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1001\/archneurol.2010.226","volume":"68","author":"LZ Leng","year":"2011","unstructured":"Leng LZ, Fink ME, Iadecola C (2011) Spreading depolarization: a possible new culprit in the delayed cerebral ischemia of subarachnoid hemorrhage. Arch Neurol 68(1):31\u201336. https:\/\/doi.org\/10.1001\/archneurol.2010.226","journal-title":"Arch Neurol"},{"issue":"3","key":"2273_CR9","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/bja\/aes264","volume":"109","author":"MJ Rowland","year":"2012","unstructured":"Rowland MJ, Hadjipavlou G, Kelly M, Westbrook J, Pattinson KT (2012) Delayed cerebral ischaemia after subarachnoid haemorrhage: looking beyond vasospasm. Br J Anaesth 109(3):315\u2013329. https:\/\/doi.org\/10.1093\/bja\/aes264","journal-title":"Br J Anaesth"},{"issue":"11","key":"2273_CR10","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1038\/jcbfm.2008.74","volume":"28","author":"MD Vergouwen","year":"2008","unstructured":"Vergouwen MD, Vermeulen M, Coert BA, Stroes ES, Roos YB (2008) Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia. J Cereb Blood Flow Metab 28(11):1761\u20131770. https:\/\/doi.org\/10.1038\/jcbfm.2008.74","journal-title":"J Cereb Blood Flow Metab"},{"issue":"10","key":"2273_CR11","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1161\/STROKEAHA.110.589275","volume":"41","author":"MD Vergouwen","year":"2010","unstructured":"Vergouwen MD, Vermeulen M, van Gijn J, Rinkel GJ, Wijdicks EF, Muizelaar JP, Mendelow AD, Juvela S, Yonas H, Terbrugge KG, Macdonald RL, Diringer MN, Broderick JP, Dreier JP, Roos YB (2010) Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke 41(10):2391\u20132395. https:\/\/doi.org\/10.1161\/STROKEAHA.110.589275","journal-title":"Stroke"},{"key":"2273_CR12","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3389\/fneur.2014.00134","volume":"5","author":"AS Sarrafzadeh","year":"2014","unstructured":"Sarrafzadeh AS, Vajkoczy P, Bijlenga P, Schaller K (2014) Monitoring in neurointensive care - the challenge to detect delayed cerebral ischemia in high-grade aneurysmal SAH. Front Neurol 5:134. https:\/\/doi.org\/10.3389\/fneur.2014.00134","journal-title":"Front Neurol"},{"issue":"5","key":"2273_CR13","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.3171\/2020.3.JNS20375","volume":"134","author":"M Veldeman","year":"2020","unstructured":"Veldeman M, Albanna W, Weiss M, Conzen C, Schmidt TP, Schulze-Steinen H, Wiesmann M, Clusmann H, Schubert GA (2020) Invasive neuromonitoring with an extended definition of delayed cerebral ischemia is associated with improved outcome after poor-grade subarachnoid hemorrhage. J Neurosurg 134(5):1527\u20131534. https:\/\/doi.org\/10.3171\/2020.3.JNS20375","journal-title":"J Neurosurg"},{"issue":"3","key":"2273_CR14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1056\/NEJMcp1605827","volume":"377","author":"MT Lawton","year":"2017","unstructured":"Lawton MT, Vates GE (2017) Subarachnoid hemorrhage. N Engl J Med 377(3):257\u2013266. https:\/\/doi.org\/10.1056\/NEJMcp1605827","journal-title":"N Engl J Med"},{"issue":"1","key":"2273_CR15","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1161\/STROKEAHA.114.006498","volume":"47","author":"RL Macdonald","year":"2016","unstructured":"Macdonald RL (2016) Origins of the concept of vasospasm. Stroke 47(1):e11-15. https:\/\/doi.org\/10.1161\/STROKEAHA.114.006498","journal-title":"Stroke"},{"issue":"3","key":"2273_CR16","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s12028-022-01545-9","volume":"37","author":"TP Schmidt","year":"2022","unstructured":"Schmidt TP, Weiss M, Hoellig A, Nikoubashman O, Schulze-Steinen H, Albanna W, Clusmann H, Schubert GA, Veldeman M (2022) Revisiting the timeline of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: toward a temporal risk profile. Neurocrit Care 37(3):735\u2013743. https:\/\/doi.org\/10.1007\/s12028-022-01545-9","journal-title":"Neurocrit Care"},{"issue":"3","key":"2273_CR17","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3171\/jns.1996.84.3.0405","volume":"84","author":"FG Barker 2nd","year":"1996","unstructured":"Barker FG 2nd, Ogilvy CS (1996) Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a metaanalysis. J Neurosurg 84(3):405\u2013414. https:\/\/doi.org\/10.3171\/jns.1996.84.3.0405","journal-title":"J Neurosurg"},{"issue":"1","key":"2273_CR18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3171\/jns.1991.74.1.0008","volume":"74","author":"J Ohman","year":"1991","unstructured":"Ohman J, Servo A, Heiskanen O (1991) Long-term effects of nimodipine on cerebral infarcts and outcome after aneurysmal subarachnoid hemorrhage and surgery. J Neurosurg 74(1):8\u201313. https:\/\/doi.org\/10.3171\/jns.1991.74.1.0008","journal-title":"J Neurosurg"},{"issue":"6674","key":"2273_CR19","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1136\/bmj.298.6674.636","volume":"298","author":"JD Pickard","year":"1989","unstructured":"Pickard JD, Murray GD, Illingworth R, Shaw MD, Teasdale GM, Foy PM, Humphrey PR, Lang DA, Nelson R, Richards P et al (1989) Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ 298(6674):636\u2013642. https:\/\/doi.org\/10.1136\/bmj.298.6674.636","journal-title":"BMJ"},{"issue":"2","key":"2273_CR20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s12028-011-9605-9","volume":"15","author":"MN Diringer","year":"2011","unstructured":"Diringer MN, Bleck TP, Claude Hemphill J 3rd, Menon D, Shutter L, Vespa P, Bruder N, Connolly ES Jr, Citerio G, Gress D, Hanggi D, Hoh BL, Lanzino G, Le Roux P, Rabinstein A, Schmutzhard E, Stocchetti N, Suarez JI, Treggiari M, Tseng MY, Vergouwen MD, Wolf S, Zipfel G, Neurocritical Care S (2011) Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society\u2019s Multidisciplinary Consensus Conference. Neurocrit Care 15(2):211\u2013240. https:\/\/doi.org\/10.1007\/s12028-011-9605-9","journal-title":"Neurocrit Care"},{"issue":"2","key":"2273_CR21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000346087","volume":"35","author":"T Steiner","year":"2013","unstructured":"Steiner T, Juvela S, Unterberg A, Jung C, Forsting M, Rinkel G, European Stroke O (2013) European Stroke Organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage. Cerebrovasc Dis 35(2):93\u2013112. https:\/\/doi.org\/10.1159\/000346087","journal-title":"Cerebrovasc Dis"},{"issue":"5","key":"2273_CR22","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s00701-015-2369-9","volume":"157","author":"T Abboud","year":"2015","unstructured":"Abboud T, Andresen H, Koeppen J, Czorlich P, Duehrsen L, Stenzig J, Westphal M, Regelsberger J (2015) Serum levels of nimodipine in enteral and parenteral administration in patients with aneurysmal subarachnoid hemorrhage. Acta Neurochir (Wien) 157(5):763\u2013767. https:\/\/doi.org\/10.1007\/s00701-015-2369-9","journal-title":"Acta Neurochir (Wien)"},{"issue":"1","key":"2273_CR23","doi-asserted-by":"publisher","first-page":"100","DOI":"10.18433\/jpps30960","volume":"23","author":"FA Isse","year":"2020","unstructured":"Isse FA, Abdallah YEH, Mahmoud SH (2020) The impact of nimodipine administration through feeding tube on outcomes in patients with aneurysmal subarachnoid hemorrhage. J Pharm Pharm Sci 23(1):100\u2013108. https:\/\/doi.org\/10.18433\/jpps30960","journal-title":"J Pharm Pharm Sci"},{"issue":"3","key":"2273_CR24","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s12028-012-9670-8","volume":"16","author":"HA Choi","year":"2012","unstructured":"Choi HA, Ko SB, Chen H, Gilmore E, Carpenter AM, Lee D, Claassen J, Mayer SA, Schmidt JM, Lee K, Connelly ES, Paik M, Badjatia N (2012) Acute effects of nimodipine on cerebral vasculature and brain metabolism in high grade subarachnoid hemorrhage patients. Neurocrit Care 16(3):363\u2013367. https:\/\/doi.org\/10.1007\/s12028-012-9670-8","journal-title":"Neurocrit Care"},{"issue":"1","key":"2273_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/ANA.0b013e318224030a","volume":"24","author":"FA Rasulo","year":"2012","unstructured":"Rasulo FA, Girardini A, Lavinio A, De Peri E, Stefini R, Cenzato M, Nodari I, Latronico N (2012) Are optimal cerebral perfusion pressure and cerebrovascular autoregulation related to long-term outcome in patients with aneurysmal subarachnoid hemorrhage? J Neurosurg Anesthesiol 24(1):3\u20138. https:\/\/doi.org\/10.1097\/ANA.0b013e318224030a","journal-title":"J Neurosurg Anesthesiol"},{"issue":"1","key":"2273_CR26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s12028-015-0230-x","volume":"25","author":"N Sandow","year":"2016","unstructured":"Sandow N, Diesing D, Sarrafzadeh A, Vajkoczy P, Wolf S (2016) Nimodipine dose reductions in the treatment of patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care 25(1):29\u201339. https:\/\/doi.org\/10.1007\/s12028-015-0230-x","journal-title":"Neurocrit Care"},{"issue":"10","key":"2273_CR27","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/j.ejrad.2014.06.020","volume":"83","author":"K Dolatowski","year":"2014","unstructured":"Dolatowski K, Malinova V, Frolich AM, Schramm R, Haberland U, Klotz E, Mielke D, Knauth M, Schramm P (2014) Volume perfusion CT (VPCT) for the differential diagnosis of patients with suspected cerebral vasospasm: qualitative and quantitative analysis of 3D parameter maps. Eur J Radiol 83(10):1881\u20131889. https:\/\/doi.org\/10.1016\/j.ejrad.2014.06.020","journal-title":"Eur J Radiol"},{"key":"2273_CR28","doi-asserted-by":"publisher","first-page":"e739","DOI":"10.1016\/j.wneu.2018.09.208","volume":"121","author":"S Vulcu","year":"2019","unstructured":"Vulcu S, Wagner F, Santos AF, Reitmeir R, Soll N, Schoni D, Fung C, Wiest R, Raabe A, Beck J, Z\u2019Graggen WJ (2019) Repetitive computed tomography perfusion for detection of cerebral vasospasm-related hypoperfusion in aneurysmal subarachnoid hemorrhage. World Neurosurg 121:e739\u2013e746. https:\/\/doi.org\/10.1016\/j.wneu.2018.09.208","journal-title":"World Neurosurg"},{"issue":"5","key":"2273_CR29","doi-asserted-by":"publisher","first-page":"358","DOI":"10.4212\/cjhp.v67i5.1390","volume":"67","author":"M MacKenzie","year":"2014","unstructured":"MacKenzie M, Gorman SK, Doucette S, Green R (2014) Incidence of and factors associated with manipulation of nimodipine dosage in patients with aneurysmal subarachnoid hemorrhage. Can J Hosp Pharm 67(5):358\u2013365. https:\/\/doi.org\/10.4212\/cjhp.v67i5.1390","journal-title":"Can J Hosp Pharm"},{"issue":"10","key":"2273_CR30","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1007\/s00701-021-04837-9","volume":"163","author":"J Lunkiewicz","year":"2021","unstructured":"Lunkiewicz J, Brandi G, Willms J, Strassle C, Narula G, Keller E, Muroi C (2021) The effect of nimodipine on pulmonary function in artificially ventilated patients with aneurysmal subarachnoid hemorrhage. Acta Neurochir (Wien) 163(10):2715\u20132721. https:\/\/doi.org\/10.1007\/s00701-021-04837-9","journal-title":"Acta Neurochir (Wien)"},{"key":"2273_CR31","doi-asserted-by":"publisher","first-page":"e834","DOI":"10.1016\/j.wneu.2019.08.001","volume":"132","author":"S Hernandez-Duran","year":"2019","unstructured":"Hernandez-Duran S, Mielke D, Rohde V, Malinova V (2019) Does nimodipine interruption due to high catecholamine doses lead to a greater incidence of delayed cerebral ischemia in the setting of aneurysmal subarachnoid hemorrhage? World Neurosurg 132:e834\u2013e840. https:\/\/doi.org\/10.1016\/j.wneu.2019.08.001","journal-title":"World Neurosurg"},{"key":"2273_CR32","doi-asserted-by":"publisher","first-page":"e501","DOI":"10.1016\/j.wneu.2021.11.016","volume":"158","author":"L Mahmoud","year":"2022","unstructured":"Mahmoud L, Zullo AR, Blake C, Dai X, Thompson BB, Wendell LC, Furie KL, Reznik ME, Mahta A (2022) Safety of modified nimodipine dosing in aneurysmal subarachnoid hemorrhage. World Neurosurg 158:e501\u2013e508. https:\/\/doi.org\/10.1016\/j.wneu.2021.11.016","journal-title":"World Neurosurg"},{"issue":"8","key":"2273_CR33","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.04.024","volume":"28","author":"A Hajizadeh Barfejani","year":"2019","unstructured":"Hajizadeh Barfejani A, Rabinstein AA, Wijdicks EFM, Clark SL (2019) Poor utilization of nimodipine in aneurysmal subarachnoid hemorrhage. J Stroke Cerebrovasc Dis 28(8):2155\u20132158. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2019.04.024","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"1","key":"2273_CR34","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s12028-019-00676-w","volume":"31","author":"M Kieninger","year":"2019","unstructured":"Kieninger M, Gruber M, Knott I, Dettmer K, Oefner PJ, Bele S, Wendl C, Tuemmler S, Graf B, Eissnert C (2019) Incidence of arterial hypotension in patients receiving peroral or continuous intra-arterial nimodipine after aneurysmal or perimesencephalic subarachnoid hemorrhage. Neurocrit Care 31(1):32\u201339. https:\/\/doi.org\/10.1007\/s12028-019-00676-w","journal-title":"Neurocrit Care"},{"issue":"6","key":"2273_CR35","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1161\/STROKEAHA.108.544700","volume":"40","author":"JA Frontera","year":"2009","unstructured":"Frontera JA, Fernandez A, Schmidt JM, Claassen J, Wartenberg KE, Badjatia N, Connolly ES, Mayer SA (2009) Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition? Stroke 40(6):1963\u20131968. https:\/\/doi.org\/10.1161\/STROKEAHA.108.544700","journal-title":"Stroke"},{"key":"2273_CR36","doi-asserted-by":"publisher","first-page":"982498","DOI":"10.3389\/fneur.2022.982498","volume":"13","author":"G Hao","year":"2022","unstructured":"Hao G, Chu G, Pan P, Han Y, Ai Y, Shi Z, Liang G (2022) Clinical effectiveness of nimodipine for the prevention of poor outcome after aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Front Neurol 13:982498. https:\/\/doi.org\/10.3389\/fneur.2022.982498","journal-title":"Front Neurol"},{"issue":"7","key":"2273_CR37","doi-asserted-by":"publisher","first-page":"834","DOI":"10.2174\/187152711798072383","volume":"10","author":"GJ Liu","year":"2011","unstructured":"Liu GJ, Luo J, Zhang LP, Wang ZJ, Xu LL, He GH, Zeng YJ, Wang YF (2011) Meta-analysis of the effectiveness and safety of prophylactic use of nimodipine in patients with an aneurysmal subarachnoid haemorrhage. CNS Neurol Disord Drug Targets 10(7):834\u2013844. https:\/\/doi.org\/10.2174\/187152711798072383","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"8","key":"2273_CR38","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1161\/01.str.32.8.1860","volume":"32","author":"YB Roos","year":"2001","unstructured":"Roos YB, Levi M, Carroll TA, Beenen LF, Vermeulen M (2001) Nimodipine increases fibrinolytic activity in patients with aneurysmal subarachnoid hemorrhage. Stroke 32(8):1860\u20131862. https:\/\/doi.org\/10.1161\/01.str.32.8.1860","journal-title":"Stroke"},{"issue":"5","key":"2273_CR39","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/jcbfm.2015.13","volume":"35","author":"J Boluijt","year":"2015","unstructured":"Boluijt J, Meijers JC, Rinkel GJ, Vergouwen MD (2015) Hemostasis and fibrinolysis in delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a systematic review. J Cereb Blood Flow Metab 35(5):724\u2013733. https:\/\/doi.org\/10.1038\/jcbfm.2015.13","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"2273_CR40","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1586\/14737175.2015.1018892","volume":"15","author":"JC Serrone","year":"2015","unstructured":"Serrone JC, Maekawa H, Tjahjadi M, Hernesniemi J (2015) Aneurysmal subarachnoid hemorrhage: pathobiology, current treatment and future directions. Expert Rev Neurother 15(4):367\u2013380. https:\/\/doi.org\/10.1586\/14737175.2015.1018892","journal-title":"Expert Rev Neurother"},{"issue":"5","key":"2273_CR41","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.tiv.2005.03.007","volume":"19","author":"S Duzenli","year":"2005","unstructured":"Duzenli S, Bakuridze K, Gepdiremen A (2005) The effects of ruthenium red, dantrolene and nimodipine, alone or in combination, in NMDA induced neurotoxicity of cerebellar granular cell culture of rats. Toxicol In Vitro 19(5):589\u2013594. https:\/\/doi.org\/10.1016\/j.tiv.2005.03.007","journal-title":"Toxicol In Vitro"},{"issue":"4","key":"2273_CR42","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.neuropharm.2012.05.033","volume":"63","author":"S Hashioka","year":"2012","unstructured":"Hashioka S, Klegeris A, McGeer PL (2012) Inhibition of human astrocyte and microglia neurotoxicity by calcium channel blockers. Neuropharmacology 63(4):685\u2013691. https:\/\/doi.org\/10.1016\/j.neuropharm.2012.05.033","journal-title":"Neuropharmacology"},{"issue":"4","key":"2273_CR43","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3390\/ijms17040497","volume":"17","author":"BP Lucke-Wold","year":"2016","unstructured":"Lucke-Wold BP, Logsdon AF, Manoranjan B, Turner RC, McConnell E, Vates GE, Huber JD, Rosen CL, Simard JM (2016) Aneurysmal subarachnoid hemorrhage and neuroinflammation: a comprehensive review. Int J Mol Sci 17(4):497. https:\/\/doi.org\/10.3390\/ijms17040497","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2273_CR44","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1055\/s-0033-1355164","volume":"75","author":"C Scheller","year":"2014","unstructured":"Scheller C, Wienke A, Wurm F, Simmermacher S, Rampp S, Prell J, Rachinger J, Scheller K, Koman G, Strauss C, Herzfeld E (2014) Neuroprotective efficacy of prophylactic enteral and parenteral nimodipine treatment in vestibular schwannoma surgery: a comparative study. J Neurol Surg A Cent Eur Neurosurg 75(4):251\u2013258. https:\/\/doi.org\/10.1055\/s-0033-1355164","journal-title":"J Neurol Surg A Cent Eur Neurosurg"},{"issue":"5","key":"2273_CR45","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/WNF.0000000000000356","volume":"42","author":"R Riva","year":"2019","unstructured":"Riva R, Pegoli M, Contin M, Perrone A, Mohamed S, Zanello M (2019) Cerebrospinal fluid concentrations of nimodipine correlate with long-term outcome in aneurysmal subarachnoid hemorrhage: pilot study. Clin Neuropharmacol 42(5):157\u2013162. https:\/\/doi.org\/10.1097\/WNF.0000000000000356","journal-title":"Clin Neuropharmacol"},{"issue":"3","key":"2273_CR46","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3171\/2011.9.JNS11691","volume":"116","author":"R Dhar","year":"2012","unstructured":"Dhar R, Scalfani MT, Zazulia AR, Videen TO, Derdeyn CP, Diringer MN (2012) Comparison of induced hypertension, fluid bolus, and blood transfusion to augment cerebral oxygen delivery after subarachnoid hemorrhage. J Neurosurg 116(3):648\u2013656. https:\/\/doi.org\/10.3171\/2011.9.JNS11691","journal-title":"J Neurosurg"},{"issue":"8","key":"2273_CR47","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1097\/01.CCM.0000275392.08410.DD","volume":"35","author":"E Muench","year":"2007","unstructured":"Muench E, Horn P, Bauhuf C, Roth H, Philipps M, Hermann P, Quintel M, Schmiedek P, Vajkoczy P (2007) Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage. Crit Care Med 35(8):1844\u20131851. https:\/\/doi.org\/10.1097\/01.CCM.0000275392.08410.DD. quiz 1852","journal-title":"Crit Care Med"},{"issue":"1","key":"2273_CR48","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1161\/STROKEAHA.117.017956","volume":"49","author":"CS Gathier","year":"2018","unstructured":"Gathier CS, van den Bergh WM, van der Jagt M, Verweij BH, Dankbaar JW, Muller MC, Oldenbeuving AW, Rinkel GJE, Slooter AJC, Group HS (2018) Induced hypertension for delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a randomized clinical trial. Stroke 49(1):76\u201383. https:\/\/doi.org\/10.1161\/STROKEAHA.117.017956","journal-title":"Stroke"},{"issue":"2","key":"2273_CR49","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1161\/STROKEAHA.115.011697","volume":"47","author":"S Muhammad","year":"2016","unstructured":"Muhammad S, Guresir A, Greschus S, Scorzin J, Vatter H, Guresir E (2016) Posterior reversible encephalopathy syndrome as an overlooked complication of induced hypertension for cerebral vasospasm: systematic review and illustrative case. Stroke 47(2):519\u2013522. https:\/\/doi.org\/10.1161\/STROKEAHA.115.011697","journal-title":"Stroke"},{"issue":"4","key":"2273_CR50","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.3171\/2018.11.JNS182891","volume":"132","author":"A Pala","year":"2019","unstructured":"Pala A, Schick J, Klein M, Mayer B, Schmitz B, Wirtz CR, Konig R, Kapapa T (2019) The influence of nimodipine and vasopressors on outcome in patients with delayed cerebral ischemia after spontaneous subarachnoid hemorrhage. J Neurosurg 132(4):1096\u20131104. https:\/\/doi.org\/10.3171\/2018.11.JNS182891","journal-title":"J Neurosurg"},{"issue":"3","key":"2273_CR51","doi-asserted-by":"publisher","first-page":"e0283180","DOI":"10.1371\/journal.pone.0283180","volume":"18","author":"A Cattaneo","year":"2023","unstructured":"Cattaneo A, Wipplinger C, Geske C, Semmler F, Wipplinger TM, Griessenauer CJ, Weiland J, Beez A, Ernestus RI, Westermaier T, Kunze E, Stetter C (2023) Investigating the relationship between high-dose norepinephrine administration and the incidence of delayed cerebral infarction in patients with aneurysmal subarachnoid hemorrhage: A single-center retrospective evaluation. PLoS ONE 18(3):e0283180. https:\/\/doi.org\/10.1371\/journal.pone.0283180","journal-title":"PLoS ONE"},{"issue":"4","key":"2273_CR52","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s00228-007-0267-7","volume":"63","author":"V Soppi","year":"2007","unstructured":"Soppi V, Kokki H, Koivisto T, Lehtonen M, Helin-Tanninen M, Lehtola S, Rinne J (2007) Early-phase pharmacokinetics of enteral and parenteral nimodipine in patients with acute subarachnoid haemorrhage - a pilot study. Eur J Clin Pharmacol 63(4):355\u2013361. https:\/\/doi.org\/10.1007\/s00228-007-0267-7","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"2273_CR53","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/BF00607954","volume":"30","author":"E Vinge","year":"1986","unstructured":"Vinge E, Andersson KE, Brandt L, Ljunggren B, Nilsson LG, Rosendal-Helgesen S (1986) Pharmacokinetics of nimodipine in patients with aneurysmal subarachnoid haemorrhage. Eur J Clin Pharmacol 30(4):421\u2013425. https:\/\/doi.org\/10.1007\/BF00607954","journal-title":"Eur J Clin Pharmacol"},{"key":"2273_CR54","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.wneu.2017.03.062","volume":"102","author":"W Albanna","year":"2017","unstructured":"Albanna W, Weiss M, Conzen C, Clusmann H, Schneider T, Reinsch M, Muller M, Wiesmann M, Hollig A, Schubert GA (2017) Systemic and cerebral concentration of nimodipine during established and experimental vasospasm treatment. World Neurosurg 102:459\u2013465. https:\/\/doi.org\/10.1016\/j.wneu.2017.03.062","journal-title":"World Neurosurg"},{"issue":"1","key":"2273_CR55","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3171\/2008.7.JNS08178","volume":"110","author":"E Kronvall","year":"2009","unstructured":"Kronvall E, Undren P, Romner B, Saveland H, Cronqvist M, Nilsson OG (2009) Nimodipine in aneurysmal subarachnoid hemorrhage: a randomized study of intravenous or peroral administration. J Neurosurg 110(1):58\u201363. https:\/\/doi.org\/10.3171\/2008.7.JNS08178","journal-title":"J Neurosurg"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-023-02273-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10143-023-02273-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-023-02273-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T10:35:59Z","timestamp":1741084559000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10143-023-02273-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,9]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2273"],"URL":"https:\/\/doi.org\/10.1007\/s10143-023-02273-0","relation":{},"ISSN":["1437-2320"],"issn-type":[{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,9]]},"assertion":[{"value":"7 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the local Ethics Committee of University of L\u00fcbeck (reference 15\u2013303).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from the legal guardians of all patients included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37"}}